Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

UTI Healthcare Fund - Direct Plan Unrated
(Erstwhile UTI Pharma & Healthcare)

Value Research
-0.29%
Change from previous, NAV as on Dec 06, 2019
Category: Equity: Sectoral-Pharma
Assets: R 393 crore (As on Oct 31, 2019)
Expense: 1.76% (As on Oct 31, 2019)
GET FUND UPDATES FROM VALUE RESEARCH IN YOUR INBOX
SIP Returns
Amount
Frequency
Start Date
End Date


Please wait while we are fetching data...
Choose the best mutual funds
Reach all your financial goals. Subscribe to Mutual Fund Insight now!
Basic Details
Fund House: UTI Mutual Fund
Launch Date: Jan 01, 2013
Benchmark: S&P BSE Healthcare TRI
Riskometer: High
Risk Grade: -
Return Grade: -
Turnover: 51%
Type: Open-ended
Investment Details
Return since Launch: 9.52%
Minimum Investment (R) 5,000
Minimum Addl Investment (R) 1,000
Minimum SIP Investment (R) 500
Minimum No of Cheques 6
Minimum Withdrawal (R) -
Minimum Balance (R) 5,000
Exit Load (%) 1% for redemption within 364 days
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Fund 1.11 2.63 5.63 3.07 -1.57 0.72 -
S&P BSE Healthcare TRI -3.39 0.92 3.14 -1.65 -4.59 -1.63 -
Category 3.93 1.40 5.14 5.46 -0.28 2.04 -
Rank within Category 6 1 4 5 3 3 -
Number of funds in category 7 9 9 7 4 3 0
As on Dec 06, 2019
Peer Comparison
Fund Rating Launch 1-Year Ret 3-Year Ret 5-Year Ret Expense Ratio (%) Assets
(Cr)
UTI Healthcare Fund - Direct Plan Unrated Jan-2013 3.07 -1.57 0.72 1.76 393
Mirae Asset Healthcare Fund - Direct Plan Unrated Jul-2018 8.18 - - 0.79 358
Nippon India Pharma Fund - Direct Plan Unrated Jan-2013 2.50 2.72 4.52 1.36 2,430
SBI Healthcare Opportunities Fund - Direct Plan Unrated Jan-2013 0.86 -4.10 0.87 1.33 937
Tata India Pharma & HealthCare Fund - Direct Plan Unrated Dec-2015 8.66 1.84 - 1.16 174
Portfolio
Portfolio Aggregates
  Fund Benchmark* Category
Average Mkt Cap (Rs Cr) 25,353.58 - 23,291.84
Giant (%) - - 2.86
Large (%) 36.57 - 36.39
Mid (%) 53.37 - 51.76
Small (%) 10.06 - 11.53
Tiny (%) - - -
  Value Research Fund Style
 
Top Holdings
  Company Sector PE 3Y High 3Y Low % Assets
  Sun Pharmaceutical Inds. Healthcare 23.98 21.71 5.73 12.51
  Cipla Healthcare 21.92 9.99 3.52 9.51
  Lupin Healthcare 109.67 10.84 0.00 8.85
  Divi's Laboratories Healthcare 37.50 9.43 0.00 8.34
  Ipca Laboratories Healthcare 23.32 7.79 2.06 6.00
  Dr. Reddy's Lab Healthcare 17.82 11.34 0.00 5.72
  Cadila Healthcare Healthcare 19.04 9.87 1.26 5.57
  Aurobindo Pharma Healthcare 10.20 10.12 2.36 4.31
  Eris Lifesciences Healthcare 21.82 3.83 0.00 3.52
  Sanofi India Healthcare 40.81 6.60 0.97 3.24
   Indicates an increase or decrease or no change in holding since last portfolio
 Indicates a new holding since last portfolio
As on Oct 31, 2019
News and Analysis
Contact Information

AMC: UTI Asset Management Company Ltd

Address: UTI Tower, 'GN' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051 | Phone: 022- 66786666 / 66786354 / 1800-22-1230 | Fax: 022-26523031

Email: [email protected]

Website: www.utimf.com



Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.

Address: Karvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills, Hyderabad - 500034 | Phone: 040-23312454

Email: [email protected]

Website: www.karvymfs.com